Safety, tolerability and pharmacokinetics of intra‐articular (IA) single ascending dose of 4P‐004 in patient with Kellgren and Lawrence grade 2 to 4 osteoarthritic (OA) knee

This study is focused on a common condition called knee osteoarthritis. This is where the cartilage in your knee joint wears down over time, leading to pain, stiffness, and trouble moving. It can make everyday activities quite difficult. Unfortunately, while there are treatments to manage the symptoms, there isn't a cure yet, and researchers are always looking for new and better ways to help.

Here, scientists are testing a new medicine called 4P-004. They are giving it as a single injection directly into the knee joint. This is an early stage of testing, often called a 'Phase 1' study. At this point, the main concern isn't about whether the medicine cures the condition, but rather to carefully check if it's safe for people and how their bodies react to it. They also want to understand how the body processes the medicine – for example, how much of it reaches the knee and how long it stays there.

Understanding these basic things about safety and how the medicine works in the body is really important. It helps researchers decide if it's promising enough to continue testing in larger studies, which would then look into whether it helps reduce pain and improve movement for people with knee osteoarthritis. Every new medicine goes through these careful steps to ensure it is as safe and effective as possible.